Caspofungin exposure-response relationships in adult patients with mucosal or invasive candidiasis.

Comisar, Wendy; Sun, Peng; Li, Susan; Sable, Carole; Schwartz, Michael; Bi, Sheng; Chow, Joseph; Ngai, Angela; Winchell, Gregory; Kartsonis, Nicholas; Stone, Julie

Comisar, Wendy; Sun, Peng; Li, Susan; Sable, Carole; Schwartz, Michael; Bi, Sheng; Chow, Joseph; Ngai, Angela; Winchell, Gregory; Kartsonis, Nicholas; Stone, Julie.

Afiliación

Comisar W; Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA.
Sun P; Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA.
Li S; GlaxoSmithKline, Collegeville, PA, USA.
Sable C; Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA.
Schwartz M; Johnson & Johnson, Wayne, PA, USA.
Bi S; Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA.
Chow J; Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA.
Ngai A; Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA.
Winchell G; Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA.
Kartsonis N; AstraZeneca LP, Wilmington, DE, USA.
Stone J; Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA.

Clin Pharmacol Drug Dev ; 3(1): 43-50, 2014 Jan.

Article en En | MEDLINE | ID: mdl-27128229

Palabras clave

caspofungin; invasive candidiasis; mucosal candidiasis; pharmacodynamics; pharmacokinetics

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Clin Pharmacol Drug Dev Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google